Ionis Pharmaceuticals | IONS - Aktuelle Verpflichtungen

Aktienkurs
73.27
Täglich Wechseln
-0.82 -1.11%
Monatlich
0.78%
Jährlich
146.70%
Q2 Prognose
71.70




Aktuelle Verpflichtungen Veränderung Datum
Agios Pharmaceuticals USD 82.21M 7.45M 2025-12
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Arrowhead Research USD 347.42M 151.94M 2025-12
Astellas Pharma JPY 1.32T 873M 2025-12
BioCryst Pharmaceuticals USD 196.07M 5.83M 2025-12
BioMarin Pharmaceutical USD 759.03M 39.41M 2025-12
Celltrion KRW 4.01T 343.96B 2025-09
Cspc Pharmaceutical CNY 10.18B 65.36M 2025-12
Deva Holding AS TRY 6.43B 1.18B 2023-09
Divis Laboratories Ltd INR 17.28B 2.76B 2025-09
Esperion Therapeutics USD 300.81M 58.22M 2025-12
Exelixis USD 405.64M 31.86M 2025-12
Halozyme Therapeutics USD 177.09M 660.14M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
Kangmei Pharma CNY 5.81B 57.93M 2025-09
Knight Therapeutics CAD 165.26M 12.58M 2025-12
Laboratorios Farma EUR 199.84M 121.75M 2023-12
Malin Corporation EUR 1000K 500K 2024-12
Medical Developments International AUD 5.56M 2.26M 2025-12
Moderna USD 1.99B 306M 2025-12
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Neuren Pharmaceuticals AUD 4.34M 3.58M 2025-12
Neurocrine Biosciences USD 743.4M 105.4M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Omeros USD 85.5M 2.28M 2025-06
OPKO Health USD 146.68M 22.64M 2025-12
Organigram Holdings CAD 94.05M 32.11M 2025-12
Ovoca Bio EUR 186K 2.26M 2025-06
Pfizer USD 36.6B 1.13B 2025-09
Pharma Mar EUR 93.88M 4.94M 2025-12
PTC Therapeutics USD 968.43M 102.18M 2025-12
Qiagen NV USD 512.14M 461.26M 2025-12
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
Sartorius EUR 2.11B 145.8M 2026-03
Sino Biopharmaceutical CNY 24.85B 5.29B 2025-06
Tilray USD 259.32M 8.32M 2025-09
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12
Zealand Pharma A/S 664.96M 513.61M 2025-12
Zz Pientze Pharmaceu CNY 2.14B 1.06B 2025-09